Annual Working Capital
$837.89 M
-$439.23 M-34.39%
December 31, 2023
Summary
- As of February 8, 2025, DNA annual working capital is $837.89 million, with the most recent change of -$439.23 million (-34.39%) on December 31, 2023.
- During the last 3 years, DNA annual working capital has risen by +$484.57 million (+137.15%).
- DNA annual working capital is now -47.25% below its all-time high of $1.59 billion, reached on December 31, 2021.
Performance
DNA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$548.05 M
-$69.16 M-11.20%
September 30, 2024
Summary
- As of February 8, 2025, DNA quarterly working capital is $548.05 million, with the most recent change of -$69.16 million (-11.20%) on September 30, 2024.
- Over the past year, DNA quarterly working capital has dropped by -$289.84 million (-34.59%).
- DNA quarterly working capital is now -68.14% below its all-time high of $1.72 billion, reached on September 30, 2021.
Performance
DNA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
DNA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.4% | -34.6% |
| 3 y3 years | +137.2% | -34.6% |
| 5 y5 years | - | - |
DNA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.3% | at low | -65.5% | at low |
| 5 y | 5-year | -47.3% | +137.2% | -68.1% | +55.1% |
| alltime | all time | -47.3% | +137.2% | -68.1% | +55.1% |
Ginkgo Bioworks Holdings Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $548.05 M(-11.2%) |
| Jun 2024 | - | $617.21 M(-15.9%) |
| Mar 2024 | - | $733.98 M(-12.4%) |
| Dec 2023 | $837.89 M(-34.4%) | $837.89 M(-13.9%) |
| Sep 2023 | - | $973.38 M(-8.2%) |
| Jun 2023 | - | $1.06 B(-6.6%) |
| Mar 2023 | - | $1.14 B(-11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.28 B(-19.6%) | $1.28 B(-4.5%) |
| Sep 2022 | - | $1.34 B(-8.7%) |
| Jun 2022 | - | $1.46 B(-5.4%) |
| Mar 2022 | - | $1.55 B(-2.6%) |
| Dec 2021 | $1.59 B(+349.5%) | $1.59 B(-7.7%) |
| Sep 2021 | - | $1.72 B(+386.9%) |
| Dec 2020 | $353.32 M | $353.32 M |
FAQ
- What is Ginkgo Bioworks Holdings annual working capital?
- What is the all time high annual working capital for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual working capital year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly working capital?
- What is the all time high quarterly working capital for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly working capital year-on-year change?
What is Ginkgo Bioworks Holdings annual working capital?
The current annual working capital of DNA is $837.89 M
What is the all time high annual working capital for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual working capital is $1.59 B
What is Ginkgo Bioworks Holdings annual working capital year-on-year change?
Over the past year, DNA annual working capital has changed by -$439.23 M (-34.39%)
What is Ginkgo Bioworks Holdings quarterly working capital?
The current quarterly working capital of DNA is $548.05 M
What is the all time high quarterly working capital for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly working capital is $1.72 B
What is Ginkgo Bioworks Holdings quarterly working capital year-on-year change?
Over the past year, DNA quarterly working capital has changed by -$289.84 M (-34.59%)